Property Summary

NCBI Gene PubMed Count 28
PubMed Score 32.10
PubTator Score 33.83

Knowledge Summary


No data available


  Disease Sources (3)

Disease Target Count P-value
Atopic dermatitis 944 6.80653947552787E-5
cystic fibrosis 1670 3.46829498839509E-4
group 3 medulloblastoma 2254 0.00824110003729349
interstitial cystitis 2299 0.0303072461167273
Disease Target Count Z-score Confidence
ulcerative colitis 2087 0.0 2.0
Disease Target Count Z-score Confidence
Crohn's disease 304 3.525 1.8
psoriasis 6685 3.2 1.6


  Differential Expression (5)

Disease log2 FC p
cystic fibrosis -1.727 0.000
Atopic dermatitis 1.200 0.000
interstitial cystitis 1.500 0.030
group 3 medulloblastoma 1.900 0.008
psoriasis 4.500 0.000


Accession Q9NPH9 IL-26
Symbols AK155


  Ortholog (4)

Species Source
Chimp OMA EggNOG
Macaque OMA EggNOG Inparanoid
Platypus OMA EggNOG Inparanoid
Xenopus OMA EggNOG

Gene RIF (17)

27029915 Our study indicates that IL-26 is a potential biomarker of disease severity in pediatric asthma without signs of Th2-mediated inflammation.
26202572 IL-26 is emerging as a potentially important player in host defense and may also be a pathogenic factor in the chronic inflammatory disorders of humans. [Review]
25157980 The negative influence of IL-26 on the anti-mycobacterial activity and its constitutive presence in both serum and monocyte supernatants prompt a proposal that IL26 as a candidate gene for tuberculosis susceptibility.
23875025 IL-26 differentially modulates the infection by different enveloped viruses.
23704922 Elevated levels of IL-26 in human gastric cancer promote proliferation and survival by modulating STAT1/STAT3 signaling.
23055831 IL-26 appears as a novel proinflammatory cytokine, located upstream of the proinflammatory cascade, that may constitute a promising target to treat rheumatoid arthritis and chronic inflammatory disorders.
22622197 Identify a second enhancer element positioned between IL26 and IFNG required for both IL26 and IFNG expression. One function of this enhancer is to facilitate recruitment of RNA polymerase II to promoters of both genes.
20503287 Observational study of gene-disease association. (HuGE Navigator)
20379614 Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)
20237496 Observational study of gene-disease association. (HuGE Navigator)

AA Sequence

FYRIGNKGIYKAISELDILLSWIKKLLESSQ                                           141 - 171

Text Mined References (28)

PMID Year Title
27029915 2016 The cytokine interleukin-26 as a biomarker in pediatric asthma.
26202572 2016 Interleukin-26: An Emerging Player in Host Defense and Inflammation.
25157980 2015 Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.
23875025 2013 The cationic cytokine IL-26 differentially modulates virus infection in culture.
23704922 2013 IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation.
23128233 2012 Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
23055831 2012 IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
22622197 2012 Lineage-specific adjacent IFNG and IL26 genes share a common distal enhancer element.
21297633 2011 Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
20503287 2010 Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls.